Michael F. Rafferty

Michael F. Rafferty

Corporate Officer/Principal chez University of Kansas

Health Technology
Consumer Services
Process Industries

Profil

Michael F.
Rafferty
is Vice President of Preclinical Development for Deciphera Pharmaceuticals LLC.
He is a Member of the Editorial Board of Moleculay Pharmacology U.S.A.
Ltd.
and an Adjunct Professor of Medicinal Chemistry at the University of Kansas.
Dr. Rafferty co-founded the Medicinal and Bioorganic Chemistry Foundation in 1995 and currently serves as Treasurer.
Prior to joining Deciphera Pharmaceuticals, he was Director of CNS Diseases Research for G.D.
Searle & Co. and Director of CNS Medicinal Chemistry for Parke-Davis Pharmaceutical Research, Inc. and an Adjunct Professor of Medicinal Chemistry Department at the University of Michigan.
Previously, Dr. Rafferty worked for Warner-Lambert Co., Bristol-Myers Squibb Co. He received a PhD in Medicinal Chemistry from the University of Kansas.

Postes actifs de Michael F. Rafferty

SociétésPosteDébut
University of Kansas Corporate Officer/Principal 26/03/2009
Tous les postes actifs de Michael F. Rafferty

Anciens postes connus de Michael F. Rafferty

SociétésPosteFin
Parke-Davis Pharmaceutical Research, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
Corporate Officer/Principal -
University of Michigan Corporate Officer/Principal -
Voir l'expérience en détail de Michael F. Rafferty

Formation de Michael F. Rafferty

University of Kansas Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michael F. Rafferty

Relations

29

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

Entreprise privées4

Health Technology

Health Technology

Process Industries

Parke-Davis Pharmaceutical Research, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Michael F. Rafferty